Whilst TMEM230 variants have been identified in further studies on PD patient groups, other follow-up genetic studies have failed to detect PD-associated TMEM230 variants, and whether evidence exists for ‘proof of pathogenecity’ has been debated [109,110]. This evidence concerns the gene TMEM230 and Parkinson disease.